obesity medicine competition – The Milli Chronicle

Saturday, January 24, 2026

Latest:

Factual Version of a Story

Asia Latest News

NewsDesk Milli Chronicle January 24, 2026 affordable weight loss drugs, Alkem semaglutide approval, diabetes semaglutide India, generic GLP-1 drugs, generic Ozempic India, generic Wegovy India, healthcare affordability India, Indian drugmakers obesity race, Indian pharma industry growth, Indian pharma semaglutide, obesity drugs India, obesity medicine competition, obesity treatment market, pharma market India 2026, pharmaceutical approvals India, semaglutide generic approval, Sun Pharma obesity drug, weight loss drug demand, weight loss medicine India, Zydus weight loss drug

Indian Drugmakers Enter Obesity Treatment Market With Generic Wegovy Approval

Mumbai – India’s pharmaceutical industry is set to intensify competition in the booming obesity and diabetes drug market after regulators